Floatz logo

FENTANYL

Advanced Solid Cancers

Gachon University Gil Medical CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Advanced Solid Cancers cohort.

Asset / SponsorPhaseRating
Oxycodone
Gachon University Gil Medical Center
Phase 2B
prl3-zumab
Intra-IMMUSG Pte Ltd
Phase 2/3B
Zalifrelimab
Agenus Inc.
Phase 1/2CCC
BMS-863233
Bristol-Myers Squibb
Phase 1/2CC
Inv-6452
Shenzhen Ionova Life Sciences Co., Ltd.
Phase 1/2CC

View all 22 →

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →